Aloxi (palonosetron) is the newest drug for preventing chemotherapy-related nausea and vomiting

Aloxi (palonosetron) is the newest drug for preventing chemotherapy-related nausea and vomiting.

Aloxi is a 5-HT3 antagonist...similar to Zofran (ondansetron), Anzemet (dolasetron), and Kytril (granisetron).

But Aloxi has a much longer half-life...about 40 hours... compared to less than 8 hours for the others.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote